Zobrazeno 1 - 10
of 1 590
pro vyhledávání: '"CTCAE 4.0"'
Autor:
Marieke van Son, M.D., Max Peters, M.D., Ph.D., Marinus Moerland, Ir., Ph.D., Sandrine van de Pol, M.D., Wietse Eppinga, M.D., Jan Lagendijk, Prof., Jochem van der Voort van Zyp, Ass. prof.
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 27, Iss , Pp 1-7 (2021)
Background and purpose: Local re-treatment of radiorecurrent prostate cancer is potentially curative. However, the increased risk of severe toxicity may outweigh the opportunity of cancer control. This study aims to evaluate treatment-related toxicit
Externí odkaz:
https://doaj.org/article/d4b5d48942f04457beac99ecbd3b96c7
Autor:
Domingo-Boluda, Carolina1 (AUTHOR) domingo_carbol@gva.es, Dualde, Diego2 (AUTHOR) di.dualdeb@comv.es, Taberner-Bonastre, Teresa1 (AUTHOR) soler_mig@gva.es, Soler, Miguel1 (AUTHOR), López-Campos, Fernando3 (AUTHOR) domingo_carbol@gva.es
Publikováno v:
Cancers. Sep2024, Vol. 16 Issue 18, p3170. 14p.
Publikováno v:
Journal of Pharmaceutical Practice & Service. Nov2022, Vol. 40 Issue 6, p571-575. 5p.
Autor:
Yang, Yifan1 (AUTHOR), Zhang, Ran2 (AUTHOR), Zhong, Zhifang1 (AUTHOR), Li, Jun1 (AUTHOR) clivia.li@163.com, Feng, Yi1 (AUTHOR) fengyi@pkuph.edu.cn
Publikováno v:
Neurological Sciences. May2024, Vol. 45 Issue 5, p2289-2300. 12p.
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 81:S670
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e231291c96b0b473185422767b7081d
https://doi.org/10.1016/j.ijrobp.2011.06.922
https://doi.org/10.1016/j.ijrobp.2011.06.922
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jochem R.N. van der Voort van Zyp, Marinus A. Moerland, Sandrine M.G. van de Pol, Marieke van Son, Wietse S.C. Eppinga, Max Peters, Jan J W Lagendijk
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 27, Iss, Pp 1-7 (2021)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • Severe toxicity is as low as 3% (GU), 0% (GI) and 15% (ED). • Lower impact is predicted for patients with favorable function at baseline. • Lower dose to the urethra (D10%
Background and purpose Local re-treatment of radiorecu
Background and purpose Local re-treatment of radiorecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fee07500cf88fa8c381f21e8e2d27c4b
http://www.sciencedirect.com/science/article/pii/S2405630820301051
http://www.sciencedirect.com/science/article/pii/S2405630820301051
Autor:
Yang, Jianguo1 (AUTHOR), Li, Juncai2 (AUTHOR), Deng, Qican1 (AUTHOR), Chen, Zhenzhou1 (AUTHOR), He, Kuan1 (AUTHOR), Chen, Yajun1 (AUTHOR), Fu, Zhongxue1 (AUTHOR) fzx19990521@126.com
Publikováno v:
BMC Cancer. 3/14/2023, Vol. 23 Issue 1, p1-13. 13p.
Autor:
Jiang, Li1,2 (AUTHOR) jane.lili@foxmail.com, Zhu, Jie2 (AUTHOR), Chen, Xue1,2 (AUTHOR), Wang, Yi2 (AUTHOR), Wu, Lei2 (AUTHOR), Wan, Gang2 (AUTHOR), Han, Yongtao3 (AUTHOR), Leng, Xuefeng3 (AUTHOR), Peng, Lin3 (AUTHOR) penglinms@126.com, Wang, Qifeng2 (AUTHOR) littlecancer@163.com
Publikováno v:
Radiation Oncology. 12/30/2022, Vol. 17 Issue 1, p1-8. 8p.